Eli Lilly Canada Inc. v. Apotex Inc.
The Court awarded an elevated lump sum: it reduced Apotex’s claimed legal fees to 80% as reasonable ($5,962,545.18), granted 30% of that adjusted fees as costs ($1,788,763.55), allowed reduced disbursements of $380,281.98, and ordered total costs of $2,169,045.00 inclusive of fees, disbursements and tax, with post-judgment interest at 2% from the date of the Order; no costs awarded for this motion.
- Citation
- 2023 FC 3
- Parties
- Plaintiffs / Defendants by Counterclaim: Eli Lilly Canada Inc.; Eli Lilly and Company; Lilly del Caribe, Inc.; Lilly, S.A.; ICOS Corporation Inc.; Defendant / Plaintiff by Counterclaim: Apotex Inc.
- Court
- Federal Court
- Jurisdiction
- Canada
- Judgment Date
- 6 January 2023
- Procedural Posture
- Patent Litigation (invalidity/obviousness) / Motion for Directions on Costs Under Federal Courts Rules 400 and 403 (post Judgment)
- Outcome
- Costs award granted to Apotex in the amount ordered; no costs on the motion
- Legal Topics
- Costs Award, Lump Sum Costs, Disbursements, Post Judgment Interest, Solicitor Client Privilege, Obviousness, Anticipation, Consolidation and Allocation of Costs
- Source Language
- English
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Eli Lilly Canada Inc.; Eli Lilly and Company; Lilly del Caribe, Inc.; Lilly, S.A.; ICOS Corporation Inc.
Plaintiffs / Defendants by Counterclaim
Apotex Inc.
Defendant / Plaintiff by Counterclaim
Procedural Posture
Patent Litigation (invalidity/obviousness) / Motion for Directions on Costs Under Federal Courts Rules 400 and 403 (post Judgment)
Legal Issues
- 1 Whether elevated lump sum costs above Tariff B are justified
- 2 Appropriate percentage of actual legal fees to be awarded as lump sum
- 3 Whether disputed disbursements and expert fees are recoverable
Ratio Decidendi
The Court awarded an elevated lump sum: it reduced Apotex’s claimed legal fees to 80% as reasonable ($5,962,545.18), granted 30% of that adjusted fees as costs ($1,788,763.55), allowed reduced disbursements of $380,281.98, and ordered total costs of $2,169,045.00 inclusive of fees, disbursements and tax, with post-judgment interest at 2% from the date of the Order; no costs awarded for this motion.
Court Disposition
Costs award granted to Apotex in the amount ordered; no costs on the motion
Orders
- Apotex is awarded total costs of $2,169,045.00 inclusive of all fees, disbursements and tax
- Post-judgment interest at a rate of 2 per cent is awarded from the date of this Order on the amount awarded
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment